Best Antibiotic for Uncomplicated Skin Infections
For uncomplicated skin infections, cephalexin (500 mg orally 3-4 times daily for 5-7 days) is the recommended first-line antibiotic treatment due to its excellent coverage against the most common causative pathogens and favorable safety profile. 1
Pathogen-Based Approach
Common Pathogens in Uncomplicated Skin Infections:
- Streptococcus pyogenes (Group A Streptococcus)
- Staphylococcus aureus (methicillin-susceptible)
First-Line Treatment Options
For Non-Purulent Cellulitis (Primarily Streptococcal):
- Cephalexin: 500 mg orally 4 times daily for 5-7 days 2, 1
- Dicloxacillin: 500 mg orally 4 times daily for 5-7 days 2
- Amoxicillin-clavulanate: 875/125 mg orally twice daily for 5-7 days 1
For Mixed Infections or When Staphylococcus Is Suspected:
- Cephalexin: 500 mg orally 4 times daily for 5-7 days 2
- Clindamycin: 300-450 mg orally 3 times daily for 5-7 days (if penicillin allergic) 2, 1
When to Consider MRSA Coverage
If MRSA is suspected based on local prevalence, purulent infection, or previous MRSA infection:
- Trimethoprim-sulfamethoxazole: 1-2 double-strength tablets twice daily 2
- Clindamycin: 300-450 mg orally 4 times daily (if susceptible) 2
- Doxycycline: 100 mg orally twice daily 2, 1
Treatment Algorithm
Assess infection severity:
- Mild (no systemic symptoms, limited area): Oral antibiotics
- Moderate/severe (systemic symptoms, rapidly spreading): Consider IV antibiotics
Determine if purulent or non-purulent:
- Non-purulent: Start with beta-lactam (cephalexin preferred)
- Purulent: Incision and drainage plus antibiotic with MRSA coverage
Consider local resistance patterns:
- High MRSA prevalence areas: Lower threshold for MRSA coverage
- Low MRSA prevalence: Beta-lactams remain first choice
Special Considerations
Penicillin Allergic Patients:
- Non-severe allergy: Cephalexin may still be used
- Severe allergy (anaphylaxis): Use clindamycin 1
Diabetic Patients:
- For mild infections: Dicloxacillin, clindamycin, cephalexin, levofloxacin, or amoxicillin-clavulanate 2
- More careful monitoring and potentially broader coverage needed
Evidence Strength
Recent clinical trials have demonstrated that cephalexin is as effective as newer antibiotics for uncomplicated skin infections. A randomized controlled trial comparing cephalexin with clindamycin for uncomplicated pediatric skin infections showed no significant difference in clinical improvement (94% vs. 97%) or resolution rates (97% vs. 94%) 3.
Another study comparing moxifloxacin with cephalexin found similar clinical efficacy (90% vs. 91%) and comparable rates of Staphylococcus aureus eradication (92% vs. 93%) 4.
Common Pitfalls to Avoid
- Failure to drain abscesses: Antibiotics alone are insufficient for purulent collections; surgical drainage is essential 1
- Overlooking anaerobic infections: Consider broader coverage for deep infections or those following puncture wounds 1
- Premature discontinuation: Ensure patients complete the full course of antibiotics 1
- Unnecessary broad-spectrum coverage: For uncomplicated infections, narrow-spectrum antibiotics targeting the most likely pathogens are preferred to reduce resistance development
Duration of Therapy
The standard duration of antibiotic treatment for uncomplicated skin infections is 5-7 days 1. Longer courses may be needed for immunocompromised patients or those with inadequate response to initial therapy.